MONUMENT ADVOCACY for NOVARTIS
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Issues related to domestic healthcare and pricing; Issues related to cell, gene therapies, and radioligand therapies; Issues related to supply chain management, issues related to intellectual property; issues related to tariffs; issues related to ESRD; Most Favored Nation drug pricing policy
Foreign entity interest: Novartis AG to the degree that public policies, either laws or regulations, commercially benefit Novartis Corporation, so too Novartis AG, as its parent, will benefit.
| Lobbyist | Covered position, as disclosed |
|---|---|
| KIMBERLY ELLIS | — |
| SLOANE SALZBURG | — |
| RICH THOMAS | — |
Trade (domestic/foreign) TRD
Issues related to ongoing trade negotiations; Issues related to US/China relations; Issues related to international intellectual property; Issues related to global health; issues related to supply chain; and issues related to tariffs, issues related to ESRD.
Foreign entity interest: Novartis AG to the degree that public policies, either laws or regulations, commercially benefit Novartis Corporation, so too Novartis AG, as its parent, will benefit.
| Lobbyist | Covered position, as disclosed |
|---|---|
| KIMBERLY ELLIS | — |
| SLOANE SALZBURG | — |
| RICH THOMAS | — |
Taxation/Internal Revenue Code TAX
Issues related to US and international tax provisions; issues related to ESRD
Foreign entity interest: Novartis AG to the degree that public policies, either laws or regulations, commercially benefit Novartis Corporation, so too Novartis AG, as its parent, will benefit.
| Lobbyist | Covered position, as disclosed |
|---|---|
| KIMBERLY ELLIS | — |
| SLOANE SALZBURG | — |
| RICH THOMAS | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.